PEN 8-K SEC Filing Analysis

Latest settled — T+20d ⚠ clustered

PEN ▼ -1.63% at T+20d

SHORT call ✓ call won +1.63% · α vs SPY +4.76% · entry $324.65 → $319.37

Next anchor: T+60d in 7w

Currently $321.06 · +1.11% from $324.65 entry (call sign-flipped)

Entry anchored
May 6, 2026
via day open

T+1d

-0.75%

call +0.75% · α +1.58%

$322.23

settled 5w ago

T+5d

-0.63%

call +0.63% · α +2.14%

$322.59

settled 28d ago

T+20d

-1.63%

call +1.63% · α +4.76%

$319.37

settled 6d ago

T+60d

—

call — · α —

—

in 7w

Price Chart

Loading chart...

Executive Summary

Penumbra Q1 2026 earnings miss: diluted EPS of $0.82 missed consensus of $1.11 by 26%, and net income declined 17% YoY to $32.6M, despite revenue growing 15.6% to $374.8M. The company withdrew guidance due to the pending Boston Scientific acquisition, but the standalone operational weakness is notable.

Key Financial Metrics

Gross Margin

67.6%

Actionable Insight

The significant EPS miss and declining profitability signal weakening standalone performance, but the pending Boston Scientific acquisition provides a floor. Traders should watch for any regulatory updates on the merger and consider the stock is more tied to deal completion than fundamentals near-term.

Key Facts

Q1 2026 revenue $374.8M, up 15.6% YoY
Diluted EPS $0.82 vs consensus $1.11 (miss of 26%)
Net income $32.6M, down 17% YoY from $39.2M
Operating income $38.2M vs $40.4M in prior year
Gross margin improved to 67.6% from 66.6% in Q1 2025
No FY2026 guidance provided due to pending BSX acquisition
Acquisition-related expenses of $9.4M included in SG&A

Financial Impact

EPS miss of $0.29 (26%) against consensus; operating and net income declined YoY despite revenue growth.

epsnet incomeoperating margin

Risk Factors

Acquisition failure or delay could expose stock to full operational downside
Further earnings deterioration if acquisition closes later than expected

Market Snapshot

Exchange

NYSE

Sector

Surgical & Medical Instruments & Apparatus

Analyst Consensus

36% bullish (22 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001321732-26-000018
Document: pen-20260506.htm	0001321732-26-000018
Document: 0001321732-26-000018-index-headers.html	0001321732-26-000018
Document: 0001321732-26-000018-index.html	0001321732-26-000018
Document: 0001321732-26-000018.txt	0001321732-26-000018
8-K Data (Synthetic)	0001321732-26-000018

6 reports for PEN

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for PEN — sortable, filterable
	Type				Now
May 7, 2026 4w ago	425 BULLISH ★ 7/10	$324.65 $319.37	▼ −1.63%	▼ −4.76%	$321.06 (−1.11%)
May 6, 2026 4w ago	8-K BEARISH ★ 6/10	$324.65 $319.37	▲ +1.63%	▲ +4.76%	$321.06 (+1.11%)
Apr 29, 2026 5w ago	DEFA14A NEUTRAL ★ 2/10	$326.48 $318.30	▼ −2.51%	▼ −7.73%	$321.06 (−1.66%)
Apr 17, 2026 7w ago	425 NEUTRAL ★ 4/10	$329.71 $326.54	▼ −0.96%	▼ −5.16%	$321.06 (−2.62%)
Apr 1, 2026 9w ago	DEFM14A BULLISH ★ 8/10	$330.36 $326.48	▼ −1.17%	▼ −11.05%	$321.06 (−2.82%)
Feb 25, 2026 14w ago	8-K MIXED ★ 7/10	$338.67 $336.27	▼ −0.71%	▲ +4.53%	$321.06 (−5.20%)

US Market Status

Market Closed — Opens Thu (11h 12m)

Related Tickers

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access